Silo Pharma, Inc. (SILO) Institutional Ownership

Ownership Summary

Silo Pharma, Inc. (NASDAQ:SILO) has 15 institutional investors that have filed 13F reports for the period ending December 2025.

• Collectively, these holders controlled 13.0% of Silo Pharma's outstanding shares in December 2025, down from 16.6% in September 2025.
• They increased total shares held in Silo Pharma by 113.36% from last quarter, and the number of investors in SILO decreased 6.25% annually.
• Activity in SILO broke down as 8 buyers, 4 sellers, and 3 unchanged among 15 total holders.
• Institutional investors collectively held 1.21Mn shares in Silo Pharma as of December 2025, up by 644.82K shares quarter on quarter, and up 1.03Mn shares year over year.
• AdvisorShares Investments LLC is the top holder of Silo Pharma as of December 31, 2025, with 599.51K shares representing 6.42% of outstanding stock.
• The biggest buyers of Silo Pharma for the quarter ending December 2025 included DRW Securities, LLC (333.73K), AdvisorShares Investments LLC (234.63K), XTX Topco Ltd (56.9K), GEODE CAPITAL MANAGEMENT, LLC (53.31K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.58K).
• Leading sellers of Silo Pharma shares for the quarter ending December 2025 were Virtu Financial LLC (89.37K), UBS Group AG (2.94K), Bank Of America Corp /De/ (44), Tower Research Capital LLC (TRC) (12).
• According to Business Quant data, leading holders of SILO for December 2025 are AdvisorShares Investments LLC (599.51K), DRW Securities, LLC (333.73K), GEODE CAPITAL MANAGEMENT, LLC (92.9K), XTX Topco Ltd (56.9K), JANE STREET GROUP, LLC (34.37K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.58K), VANGUARD GROUP INC (24.32K), Virtu Financial LLC (18.42K), State Street Corp (12.5K), UBS Group AG (6.04K).